Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
NCT ID NCT07036536
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This registry study follows 1,000 people who plan to transfer a non-euploid embryo—one with an abnormal number of chromosomes—at fertility clinics in The Prelude Network. The goal is to track how often these embryos implant and result in a positive pregnancy test. By gathering this data, researchers hope to learn more about the potential of non-euploid embryos and inform future fertility care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This registry could help doctors better understand which non-euploid embryos might lead to successful pregnancies, potentially improving fertility treatment decisions.
- What could go wrong
- As an observational registry, it cannot prove cause and effect. Results may vary across clinics and may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients planning a non-euploid embryo transfer (NEET) at a fertility clinic in The Prelude Network.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient is planning a non-euploid embryo transfer (NEET) at a fertility clinic in The Prelude Network. * Patient has signed informed consent to participate in the registry. Exclusion Criteria: * Not applicable
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aneuploidy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Inception Fertility Research Institute
RECRUITINGHouston, Texas, 77081, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The hidden handshake that decides whether an embryo implants
- Do infertility treatments leave a metabolic mark on children?
- Could a Woman's biological clock also predict her Heart's future?
- Sperm sorting showdown: can a microchip pick the best sperm for pregnancy?
- Could your genes predict when fertility fades?
- Can virtual reality goggles take the sting out of a fertility procedure?